Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study.
Teruhiko HiguchiTadafumi KatoMari MiyajimaKei WatabeTakahiro MasudaKatsuhiko HagiJun IshigookaPublished in: International journal of bipolar disorders (2021)
JapicCTI-132319, clinicaltrials.gov-NCT01986114.